On September 2, 2025, Perspective Therapeutics, Inc. increased its Board of Directors from five to six members and appointed Maya Martinez-Davis to fill the new position, effective September 3, 2025. Martinez-Davis will receive an annual cash retainer of $60,000 and 75,000 share options, with a grant date fair value capped at $450,000.